These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31171490)

  • 21. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
    Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
    Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive lacosamide for focal epilepsy: an open-label trial evaluating the impact of flexible titration and dosing on safety and seizure outcomes.
    Baulac M; Coulbaut S; Doty P; McShea C; De Backer M; Bartolomei F; Vlaicu M
    Epileptic Disord; 2017 Jun; 19(2):186-194. PubMed ID: 28597842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy.
    Scott LJ
    Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.
    Kim JS; Kim H; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H
    Brain Dev; 2014 Jun; 36(6):510-5. PubMed ID: 23948372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
    Vossler DG; Knake S; O'Brien TJ; Watanabe M; Brock M; Steiniger-Brach B; Williams P; Roebling R;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1067-1075. PubMed ID: 32817358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Tolerability of Lacosamide for Focal Epileptic Patients: Study from Epilepsy Clinic in Makkah.
    Alkhotani A; Abualula H; Almatrafi Y; Ghomiem S; Alaa A
    CNS Neurol Disord Drug Targets; 2021; 20(1):87-97. PubMed ID: 32814542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
    Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
    Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with lacosamide in a series of children with drug-resistant focal epilepsy.
    Guilhoto LM; Loddenkemper T; Gooty VD; Rotenberg A; Takeoka M; Duffy FH; Coulter D; Urion D; Bourgeois BF; Kothare SV
    Pediatr Neurol; 2011 Jun; 44(6):414-9. PubMed ID: 21555051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years.
    French JA; Cleary E; Dlugos D; Farfel G; Farrell K; Gidal B; Grzeskowiak CL; Gurrell R; Harden C; Stalvey TJ; Tsai J; Wirrell EC; Blum D; Fountain N
    Epilepsia; 2022 Oct; 63(10):2664-2670. PubMed ID: 35835554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trial.
    Ferreira JA; Le Pichon JB; Abdelmoity AT; Dilley D; Dedeken P; Daniels T; Byrnes W
    Seizure; 2019 Oct; 71():166-173. PubMed ID: 31374487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Tolerability of Lacosamide in the Treatment of Children With Refractory Generalized Epilepsy.
    Miskin C; Khurana DS; Valencia I; Legido A; Hasbani DM; Carvalho KS
    J Child Neurol; 2016 Jun; 31(7):925-8. PubMed ID: 26887412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age].
    Ma YP; Deng J; Fu ZR; Chen CH; Wang XH; Wang X; Weng JW; Shen YH
    Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):983-988. PubMed ID: 37899337
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of lacosamide by focal seizure subtype.
    Sperling MR; Rosenow F; Faught E; Hebert D; Doty P; Isojärvi J
    Epilepsy Res; 2014 Oct; 108(8):1392-8. PubMed ID: 25082395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: a meta-analysis.
    Hemery C; Ryvlin P; Rheims S
    Epilepsia; 2014 Nov; 55(11):1789-99. PubMed ID: 25182978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
    Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
    J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
    Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
    Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
    Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.